MedTrace Logo

Assessment of Patients Quality of Life Treated With Three ARTHRUM H 2% Joint Injections

NCT02840422 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2024-01-19

No results posted yet for this study

Summary

The reduction of functional limits and disablilities induced by knee osteoarthritis as well as improvement of patients quality of life is a public health need registered amongst the priorities established by the French law of August 9th 2004 relative to Public Health policy. However, the response to this need is not limited to treatment with health products.

This clinical trial in real life on ARTHRUM H 2% device aims to analyse patients quality of life treated by intraarticular injections, eventually for several years, by difference of usual clinical trials.

This open, prospective, multicentric study aims to analyse, in patient care, the impact of three intraarticular injections of ARTHRUM H 2% on quality of life over a period of 6 months (D180) in the symptomatic treatment of knee osteoarthritis.

Conditions

Interventions

DEVICE

ARTHRUM H 2%

ARTHRUM H 2%

Sponsors & Collaborators

  • LCA Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • CHRISTIAN PASCARETTI, MD · Le Ronceray Rhumatologie

  • Paolo INSALACO, MD · Le Ronceray Rhumatologie

  • ANTOINE LESORT, MD · Hopital Prive des Peupliers

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-03
Primary Completion
2016-12-08
Completion
2017-07-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02840422 on ClinicalTrials.gov